- Home
- ACET vs MDIA Comparison
ACET vs MDIA Comparison
Compare ACET & MDIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- MDIA
- Stock Information
- Founded
- ACET 1947
- MDIA 2019
- Country
- ACET United States
- MDIA United States
- Employees
- ACET N/A
- MDIA N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- MDIA Broadcasting
- Sector
- ACET Health Care
- MDIA Consumer Discretionary
- Exchange
- ACET Nasdaq
- MDIA Nasdaq
- Market Cap
- ACET 61.2M
- MDIA 51.8M
- IPO Year
- ACET N/A
- MDIA N/A
- Fundamental
- Price
- ACET $0.76
- MDIA $1.25
- Analyst Decision
- ACET Buy
- MDIA
- Analyst Count
- ACET 6
- MDIA 0
- Target Price
- ACET $6.00
- MDIA N/A
- AVG Volume (30 Days)
- ACET 406.7K
- MDIA 709.6K
- Earning Date
- ACET 08-12-2025
- MDIA 05-20-2025
- Dividend Yield
- ACET N/A
- MDIA N/A
- EPS Growth
- ACET N/A
- MDIA N/A
- EPS
- ACET N/A
- MDIA N/A
- Revenue
- ACET N/A
- MDIA $116,895,000.00
- Revenue This Year
- ACET N/A
- MDIA N/A
- Revenue Next Year
- ACET N/A
- MDIA N/A
- P/E Ratio
- ACET N/A
- MDIA N/A
- Revenue Growth
- ACET N/A
- MDIA 268.03
- 52 Week Low
- ACET $0.45
- MDIA $0.79
- 52 Week High
- ACET $1.70
- MDIA $5.73
- Technical
- Relative Strength Index (RSI)
- ACET 57.89
- MDIA 53.75
- Support Level
- ACET $0.58
- MDIA $1.11
- Resistance Level
- ACET $0.82
- MDIA $1.38
- Average True Range (ATR)
- ACET 0.04
- MDIA 0.12
- MACD
- ACET 0.01
- MDIA -0.00
- Stochastic Oscillator
- ACET 74.79
- MDIA 45.45
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.